Clinical Trials on Embryo Viability in Germany

Total 50 results

gyn-medicum Göttingen

Recruiting

Targeted Metabolomics and Spent Embryo Culture Medium

Metabolomics | Embryo Culture Media

Germany
Ludwig-Maximilians - University of Munich

Completed

Effects of Continuous Noninvasive Arterial Pressure Measurement on Anaesthesia (ANIKOB)

Blood Pressure Stability in General Anaesthesia

Germany
University of Erlangen-Nürnberg Medical School

Completed

Effects of Whole-Body Electromyostimulation on Golf Performance

Muscle Strength | Trunk Stability | Golf Specific Performance

Germany
Charite University, Berlin, Germany

Terminated

Action of Caffeinated and Decaffeinated Espresso on Autonomic Function

Influence of Espresso on Heart Rate Variability

Germany
Hummel, Christiane
Ludwig-Maximilians - University of Munich

Completed

Driving Ability of Drug Dependant Patients in Maintenance Therapy

Driving Ability

Germany
RWTH Aachen University

Recruiting

Evaluating the Treatment in the MZEB Aachen (EvalMZEB)

Intellectual Disability | Disability Physical

Germany
Johannes Gutenberg University Mainz

Completed

Perfusion Index (PI) and Pleth Variability Index (PVI) in Patients With Interscalene Blocks in Orthopedic Surgery (PI-PVI)

Orthopedic Surgery | Perfusion Index and Pleth Variability Index | Interscalene Blocks

Germany
RWTH Aachen University

Completed

The Use of Myocardial Deformation Imaging

Myocardial Viability in Ischemic Left Ventricular Dysfunction | Prediction for Improvement in Cardiac Function After Revascularization Therapy

Germany
Technische Universität Dresden

Completed

Psychotropic Medication and Psychotherapeutic Treatment of Adults With Intellectual Disabilities (PROMPT-ID)

Intellectual Disability

Germany
Technical University of Munich
Bayer; Organon; Sanofi-Synthelabo; AOK Bayern; Ratiopharm GmbH; Berlin-Chemie Menarini and other collaborators

Terminated

Prevention of Stroke and Dementia in Primary Care (INVADE)

Stroke | Dementia | Disability

Germany
Linde AG

Completed

MIND Score for Prolonged Mechanical Ventilation (MIND)

Functional Test, COPD, Neuromuscular Disorders, Mechanical Ventilation, Weaning, Disability

Argentina, Colombia, Germany
Medical University of Graz
Medical University of Vienna; University of Alberta; Poznan University of Medical... and other collaborators

Recruiting

2 Year Follow up of COSGOD III (COSGODIII-FU)

Death | Neurodevelopmental Disability

Austria, Germany, Slovenia, Canada, Ireland, Italy, Poland
University Hospital Schleswig-Holstein

Completed

Intravenous Beta-blockade for Improvement of Autonomic Activity

Hypertension | Tachycardia | Heart Rate Variability

Germany
Robert Bosch Gesellschaft für Medizinische Forschung...
Norwegian University of Science and Technology

Completed

Evaluation of the Measurement Properties of a 5 Time Repeated Instrumented Timed Up and Go (5iTUG) (5iTUG)

Cognitive Impairment | Physical Disability | Gait Disorder, Sensorimotor | Balance | Activity of Daily Living | Measurement Properties of 5iTUG | Leg Strength

Germany
Technische Universität Dresden
German Federal Ministry of Education and Research

Completed

Mental Health Care Provision for Adults With Intellectual Disability and a Mental Disorder (MEMENTA)

Intellectual Disability | Mental Disorder

Germany
Fachklinik Hornheide an der Universität Münster
Westfälische Wilhelms-Universität Münster; Deutsche Rentenversicherung

Completed

Employment and Quality of Life in Patients With Malignant Melanoma

Quality of Life | Work Ability | Malignant Melanoma of Skin

Germany
University of Heidelberg Medical Center

Unknown

Group-based Training for Parents of Children With Dyslexia

Dyslexia | Reading Disability | Reading Disorder | Developmental Reading Disorder

Germany
Novartis Pharmaceuticals

Terminated

EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes (EXPLAIN)

Fragile-X Syndrome

Germany
University Hospital Heidelberg

Completed

Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III

Mucopolysaccharidosis Type I | Mucopolysaccharidosis Type II | Coping Behavior | Mucopolysaccharidosis Type III | Behavior Disorders

Germany
Jacobs University Bremen gGmbH
Dr. Becker Hospital Group; Dr. Becker Klinik Möhnesee; Dr. Becker Burg-Klinik... and other collaborators

Completed

Feasibility and Benefits of Digital Services During the COVID19 Pandemic (AnhandCOV19)

Anxiety | Communication | Psychological Distress | Health Risk Behaviors | Healthy Lifestyle | Psychological Adjustment | Psychological Stress | Psychological Disorder | Behavior, Health | Psychological Disease | Psychosomatic Disorder | Psychological Adaptation | Health Care Seeking Behavior | Psychological Disability and other conditions

Germany
Novo Nordisk A/S

Completed

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

Prader-Willi Syndrome | Genetic Disorder

Germany, Denmark, Switzerland
University Hospital Tuebingen

Recruiting

First Trimester Screening for Trisomy 21, 18, 13 and 22q11.2 Deletion Syndrome (ReFaPo02)

Pregnancy

Germany
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) (BioSanfilippo)

Developmental Delay | Mental Retardation

Germany, India, Sri Lanka, Egypt
University Hospital, Toulouse
Epidemiological and Clinical Research Information Network; International Clinical...

Completed

Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome (OTBB3)

Prader-Willi Syndrome

France, Belgium, Germany
Leipzig University Medical Center

Recruiting

Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD_QoL)

X-linked Adrenoleukodystrophy

Germany
Leipzig University Medical Center
European Leukodystrophy Association

Completed

SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)

X-linked Adrenoleukodystrophy

Germany
Zimmer, GmbH

Active, not recruiting

Zimmer POLAR Persona - TKA (EMEA Study)

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis | Polyarthritis | Severe Knee Pain | Severe Knee Disability

France, Spain, United Kingdom, Austria, Germany, Netherlands
University Hospital, Toulouse
European Society for Paediatric Endocrinology

Completed

PWS European Blood Bank for Infants and Controls From 0 to 48 Months

Prader-Willi Syndrome

Sweden, Belgium, France, Germany, Netherlands, United Kingdom
Rocket Pharmaceuticals Inc.

Recruiting

Danon Disease Natural History Study

Danon Disease

United States, Germany
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Mucopolysaccharidosis II

United States, Germany, Philippines
MedDay Pharmaceuticals SA

Completed

MD1003-AMN MD1003 in Adrenomyeloneuropathy

Adrenoleukodystrophy | Adrenomyeloneuropathy | AMN

France, Germany, Spain
Minoryx Therapeutics, S.L.

Active, not recruiting

A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT) (NEXUS)

Cerebral Adrenoleukodystrophy

Spain, Germany, France, Argentina
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) (BioGM1/BioGM2)

Seizures | Mental Retardation | Hepato-splenomegaly | Dysostosis Multiplex

Egypt, Germany, India, Sri Lanka
Takeda
Takeda Development Center Americas, Inc.

Active, not recruiting

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

Hunter Syndrome

United States, Germany, Malaysia, Philippines, Thailand, Dominican Republic, Serbia, Vietnam
Dr. Rebecca Schule
German Research Foundation; German Center for Neurodegenerative Diseases (DZNE)

Recruiting

Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias (SPAX-PBP)

Spastic Ataxia

Canada, France, Germany, Italy, Netherlands, Turkey, United Kingdom
Shire

Completed

Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)

Mucopolysaccharidosis II

United States, United Kingdom, Brazil, Germany
bluebird bio

Completed

A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD)

United States, France, Germany, Italy, Netherlands, United Kingdom
Viking Therapeutics, Inc.

Recruiting

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

United States, France, Germany, Italy, United Kingdom
Minoryx Therapeutics, S.L.

Active, not recruiting

A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients. (Advance)

Adrenoleukodystrophy

Spain, United States, Hungary, France, Germany, Italy, Netherlands, United Kingdom
bluebird bio

Completed

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD)

United States, Germany, Argentina, Australia, France, United Kingdom
CENTOGENE GmbH Rostock

Terminated

European Alpha-Mannosidosis Participant (EUMAP)

Deafness | Immunodeficiency | Mental Retardation | Gingival Hypertrophy | Skeletal Abnormalities | Facial Dysmorphism

Germany, Switzerland
Novartis Pharmaceuticals

Terminated

Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome

Fragile X Syndrome

Germany, United States, Switzerland, Australia, Canada, Denmark, France, Italy, United Kingdom, Spain
Novartis Pharmaceuticals

Terminated

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Fragile X Syndrome

United States, Belgium, Australia, Israel, Switzerland, Germany, Denmark, Italy, Netherlands, Spain, Sweden, United Kingdom, France
JCR Pharmaceuticals Co., Ltd.

Recruiting

A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

Mucopolysaccharidosis II

United States, Germany, Spain, France, Brazil, Argentina, Turkey, United Kingdom, Poland, Italy
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome

Fragile X Syndrome

United States, Switzerland, Germany, Australia, Canada, Denmark, France, Italy, Spain, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome

Fragile X Syndrome

United States, Belgium, Australia, Israel, Switzerland, Germany, France, Canada, Denmark, Indonesia, Italy, Netherlands, Spain, Sweden, Turkey, United Kingdom
bluebird bio

Active, not recruiting

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

Cerebral Adrenoleukodystrophy (CALD) | Adrenoleukodystrophy (ALD) | X-Linked Adrenoleukodystrophy (X-ALD)

United States, Argentina, Australia, Brazil, France, Germany, Netherlands, United Kingdom, Italy
bluebird bio

Terminated

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD) | Adrenoleukodystrophy (ALD) | X-Linked Adrenoleukodystrophy (X-ALD)

United States, United Kingdom, Argentina, Canada, Germany, Italy, Netherlands
Denali Therapeutics Inc.

Recruiting

A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) (COMPASS)

Mucopolysaccharidosis II

United States, Spain, United Kingdom, Czechia, France, Canada, Italy, Belgium, Netherlands, Germany, Argentina, Sweden, Turkey, Brazil, Colombia
Shire

Completed

Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

Hunter Syndrome | Mucopolysaccharidosis II (MPS II)

United States, France, United Kingdom, Germany, Sweden, Spain, Brazil, Canada, Italy, Romania

Clinical Trials on Embryo Viability in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations